Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
GVK BIO has announced the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of Directors.
read more
Monday, September 09, 2019
GVK BIO has announced the promotion of Sudhir Kumar Singh, Ph.D., to the position of COO and the appointment of Ramesh Subramanian, Ph.D., as its Chief Commercial Officer.
read more
Monday, February 01, 2021
Gyros Protein Technologies has announced the introduction of Gyrolab Bioaffy 4000 CD for immunoassay applications in biotherapeutic workflows.
read more
Wednesday, October 11, 2017
Gyros Protein Technologies AB has signed a distribution agreement with Euro Diagnostica, a full service assay solution company.
read more
Wednesday, March 09, 2022
H Clinical announced that the company is expanding logistics service capabilities to support decentralized clinical trials (DCTs) in emerging markets throughout Latin America. Coordinated logistics and depots better facilitate multi-site and multi-...
read more
H.E.L Group (H.E.L), a developer and manufacturer of laboratory tools for process optimization, safety, and scale-up, announced that it has expanded its operations in North America, with the establishment of a West Coast hub in California, and a ...
read more
Haemonetics and CSL Plasma have announced an agreement to transfer ownership of Haemonetics' Union, South Carolina, manufacturing facility, operating assets and certain inventories to CSL Plasma.
read more
Monday, November 25, 2019
HALIX has announced the opening of its new 6,700 m² cGMP facility at the Leiden Bio Science Park.
read more
Wednesday, April 15, 2020
HALIX has joined a consortium of partners to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine being developed by the University’s Jenner Institute.
read more
HALIX announced they have met their major milestone with the interim delivery of their new 6,700 m2 cGMP facility in Leiden Bio Science Park.
read more
Wednesday, December 23, 2020
HALIX has signed an agreement with AstraZeneca for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine.
read more
ExxPharma Therapeutics and Halo Pharmaceutical have entered into a collaboration agreement to develop and manufacture drug products for customers of Halo and ExxPharma using ExxPharma's drug delivery systems and twin screw extrusion-based ...
read more
Halo Pharma announces the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications.
read more
Tuesday, December 16, 2025
Halo Pharma is expanding its manufacturing capabilities at its Whippany, New Jersey facility with the addition of a Gerteis Macro-Pactor®, a versatile roller compactor that enhances the company’s ability to manage complex formulations, improve ...
read more
Tuesday, October 14, 2025
Halo Pharma appointed Laurent Malgouyres as Site Director for its facility in Mirabel, Quebec, Canada. In his new role, Malgouyres will oversee production, quality, and overall site performance.
read more